Tag: ndma

Generic Fortamet Diabetes Drug Recalled for Carcinogens

Generic Fortamet Diabetes Drug Recalled for Carcinogens

Lupin Pharmaceuticals recalled a generic version of the diabetes medication FortametĀ® due to high levels of a carcinogenic chemical.

/ June 11, 2020
Two More Companies Recall Metformin ER Diabetes Drugs for Carcinogens

Two More Companies Recall Metformin ER Diabetes Drugs for Carcinogens

Teva Pharmaceuticals and Marksans Pharma Ltd. have recalled the diabetes drug metformin after they tested positive for high levels of a cancer-causing chemical impurity.

/ June 8, 2020
Apotex Corp. Recalls Extended-Release Metformin for Cancer-Causing Chemical

Apotex Corp. Recalls Extended-Release Metformin for Carcinogens

Apotex Corp. recalled all lots of extended-release metformin (500-mg) after FDA tests found high levels of a cancer-causing chemical.

/ June 1, 2020
FDA Finds High Levels of Carcinogen in Diabetes Drug Metformin

FDA Finds High Levels of Carcinogen in Diabetes Drug Metformin

Tests on some extended-release versions of the diabetes drug metformin found high levels of a cancer-causing chemical impurity called N-Nitrosodimethylamine (NDMA), according to the FDA.

/ May 28, 2020
Nizatidine Liquid Heartburn Drug Recalled for NDMA Contamination

Nizatidine Liquid Heartburn Drug Recalled for NDMA Contamination

Amneal Pharmaceuticals recalled bottles of a liquid heartburn drug called nizatidine due to a cancer-causing chemical impurity.

/ April 16, 2020
Pharmacy Demands Metformin Recall for NDMA Carcinogens

Pharmacy Demands Metformin Recall for NDMA Carcinogens

A pharmacy is recommending recalls for the diabetes drug metformin after tests found excessive levels of a cancer-causing chemical.

/ March 3, 2020
Nizatidine Recalled After Tests Detect Toxic Carcinogen

Nizatidine Recalled After Tests Detect Toxic Carcinogen

Mylan Pharmaceuticals recalled 3 batches of the ulcer medication Nizatidine due to contamination with a cancer-causing chemical.

/ January 10, 2020
Sandoz Recalls Generic Zantac for Carcinogenic Impurity

Sandoz Recalls Generic Zantac for Carcinogenic Impurity

Sandoz recalled generic Zantac (ranitidine) due to a potential risk of carcinogenic impurities.

/ September 25, 2019